Use of specific antimicrobials for COVID-19: should we prescribe them now or wait for more evidence?
- PMID: 32439730
- PMCID: PMC10016879
- DOI: 10.1136/postgradmedj-2020-137990
Use of specific antimicrobials for COVID-19: should we prescribe them now or wait for more evidence?
Keywords: infectious diseases; therapeutics.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Drug repurposing for COVID-19: a potential threat of self-medication and controlling measures.Postgrad Med J. 2021 Nov;97(1153):742-743. doi: 10.1136/postgradmedj-2020-138447. Epub 2020 Aug 26. Postgrad Med J. 2021. PMID: 32848085 Free PMC article. No abstract available.
Comment on
-
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18. N Engl J Med. 2020. PMID: 32187464 Free PMC article. Clinical Trial.
References
-
- WHO . Landscape analysis of candidate therapeutics for COVID-19. Available: https://app.powerbi.com/view?r=eyJrIjoiNjQxZWZhOTItYzU1ZS00Y2QxLWE1ODAtO... [Accessed 10 Apr 2020].
-
- BMJ . Best practice COVID-19, BMJ best practice, 02 March 2020. Available: https://bestpractice.bmj.com/topics/en-gb/3000168/guidelines.htm [Accessed 10 Mar 2020].